Discovering a New Cancer Killer

Dr. Marek Los (2004 Research Grant) 

Marek Los’ research story is classic. While studying the process of cell death he stumbled upon a protein called apoptin which kills cancer cells while sparing healthy cells. Apoptin is sneaky. Cancer cells use certain pathways to keep themselves alive. Apoptin hijacks these pathways and redirects them to kill cancer cells. Even better, apoptin seems to work especially well in hormone refractory prostate cancer – a stage of cancer that is nearly impossible to treat. More research is needed but Los’ work may lead to new treatment options.




Subscribe to our free monthly e-newsletter!

* indicates required

 





 
PCC Spotlight
RFP: Content Development and Delivery of an Accredited Electronic Continuing Medical Education Course for Prostate Cancer Specialists

Prostate Cancer Canada invites applications from service providers interested in the development, promotion and delivery of an accredited electronic Continuing Medical Education course targeting prostate cancer specialists, including urologists.
More

Prostate Cancer Canada announces new President and CEO

Toronto, December 21, 2017 – After five successful years under the leadership and guidance of outgoing President and CEO, Rocco Rossi, Prostate Cancer Canada (PCC) is excited to announce the appointment of a most worthy successor in Peter Coleridge, past national CEO of the Canadian Mental Health Association and current national President and CEO of Big Brothers Big Sisters of Canada.
More

Université de Sherbrooke Researchers’ Findings Published in Cancer Research

Sherbrooke, November 16, 2017 – Prostate cancer, the most common cancer in men, affects one out of seven Canadian men.
More


Click here for news archive